1. Wearing SC, Hennig EM, Byrne NM, Steele JR, Hills AP. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev. 2006. 7:239–250.
Article
2. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 1995. 38:1541–1546.
3. Behrens F, Shepard N, Mitchell N. Alterations of rabbit articular cartilage by intra-articular injection of glucocorticoids. J Bone Joint Surg Am. 1975. 57:70–76.
4. Goldspink DF, Goldberg AL. Influence of pituitary growth hormone on DNA synthesis in rat tissues. Am J Physiol. 1975. 228:302–309.
Article
5. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol. 1998. 16:441–449.
6. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage. 1995. 3:213–225.
Article
7. Namiki O, Toyoshima H, Morisaki N. Therapeutic effect of intraarticular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol. 1982. 20:501–507.
8. Bail H, Klein P, Kolbeck S, Krummrey G, Weiler A, Schmidmaier G, Haas NP, Raschke MJ. Systemic application of growth hormone enhances the early healing phase of osteochondral defects-a preliminary study in micropigs. Bone. 2003. 32:457–467.
Article
9. Dunn AR. Morphoangiogenesis: a unique action of growth hormone. Microvasc Res. 2002. 63:295–303.
Article
10. Kikuchi T, Sakuta T, Yamaguchi T. Intra-articular injection of collagenase induces experimental osteoarthritis in mature rabbits. Osteoarthritis Cartilage. 1998. 6:177–186.
Article
11. Yoshimi T, Kikuchi T, Obara T, Yamaguchi T, Sakakibara Y, Itoh H, Iwata H, Miura T. Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament. Clin Orthop Relat Res. 1994. 298:296–304.
Article
12. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971. 53:523–537.
13. Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev. 2006. 58:226–242.
Article
14. Bak B, Jørgensen PH, Andreassen TT. Increased mechanical strength of healing rat tibial fractures treated with biosynthetic human growth hormone. Bone. 1990. 11:233–239.
Article
15. Coutts RD, Sah RL, Amiel D. Effects of growth factors on cartilage repair. Instr Course Lect. 1997. 46:487–494.
16. Mihara M, Higo S, Uchiyama Y, Tanabe K, Saito K. Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model. Osteoarthritis Cartilage. 2007. 15:543–549.
Article
17. Kobayashi Y, Okamoto A, Nishinari K. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology. 1994. 31:235–244.
Article
18. Brockmeier SF, Shaffer BS. Viscosupplementation therapy for osteoarthritis. Sports Med Arthrosc. 2006. 14:155–162.
Article
19. Kolbeck S, Bail H, Schmidmaier G, Alquiza M, Raun K, Kappelgard A, Flyvbjerg A, Haas N, Raschke M. Homologous growth hormone accelerates bone healing-a biomechanical and histological study. Bone. 2003. 33:628–637.
Article
20. Carpenter JE, Hipp JA, Gerhart TN, Rudman CG, Hayes WC, Trippel SB. Failure of growth hormone to alter the biomechanics of fracture-healing in a rabbit model. J Bone Joint Surg Am. 1992. 74:359–367.
Article
21. Laursen T, Jørgensen JO, Jakobsen G, Hansen BL, Christiansen JS. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. J Clin Endocrinol Metab. 1995. 80:2410–2418.
Article
22. Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly (lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res. 2000. 17:100–106.